← Back to guidelines
Thoracic Surgery3 papers

Constrictive pericarditis caused by virus

Last edited:

Overview

Constrictive pericarditis (CP) is a condition characterized by the thickening and scarring of the pericardium, leading to impaired diastolic filling of the heart. When caused by viral etiologies, it often presents insidiously with symptoms of right-sided heart failure, despite preserved left ventricular function. This condition can mimic other forms of restrictive cardiomyopathy, making accurate diagnosis crucial for appropriate management. Early recognition is essential as delayed treatment can lead to progressive heart failure and reduced quality of life. The clinical presentation typically includes exertional dyspnea, peripheral edema, and jugular venous distension, often in middle-aged individuals. Understanding the nuances of viral-induced CP is vital for clinicians to differentiate it from other causes of pericardial disease and to initiate timely interventions.

Clinical Presentation

Constrictive pericarditis caused by viral infections should be considered in the differential diagnosis of patients presenting with unexplained right heart failure symptoms, particularly when there is preserved left ventricular ejection fraction (LVEF). This constellation of symptoms often includes:

  • Exertional Dyspnea: Patients frequently report shortness of breath during physical activity, which can progressively worsen over months.
  • Peripheral Edema: Lower extremity swelling is a common finding, reflecting right-sided heart failure.
  • Jugular Venous Distension: Elevated jugular venous pressure is often observed, indicative of impaired right atrial filling.
  • Hepatojugular Reflux: This physical sign can be elicited during examination, further supporting the diagnosis.
  • Pleural Effusions: Bilateral or unilateral pleural effusions may be present, contributing to respiratory symptoms.
  • Pericardial Friction Rub: Although not always present, a pericardial friction rub heard best at the left lower sternal border can be a valuable clinical clue.
  • A notable case involved a middle-aged male who presented with a six-month history of exertional dyspnea and leg swelling, highlighting these symptoms as key manifestations of viral-induced constrictive pericarditis [PMID:23757998]. These symptoms underscore the importance of thorough clinical evaluation, especially in patients with a gradual onset of right-sided heart failure signs without significant left ventricular dysfunction.

    Diagnosis

    Accurate diagnosis of constrictive pericarditis, particularly when viral in origin, relies on a combination of clinical assessment and advanced imaging techniques. The cornerstone of the diagnostic work-up includes:

  • Comprehensive Echocardiography with Doppler: Echocardiography is pivotal in identifying characteristic features such as:
  • - Pericardial Thickening: A thickened pericardium is often visualized. - Restrictive Pericardium: Signs include diastolic septal bounce and obliteration of the right ventricular inflow and outflow tracts during diastole. - Kussmaul’s Sign: An inspiratory decrease in right atrial pressure, reflected as an increase in the size of the inferior vena cava. - Echo Doppler Patterns: Triphasic flow in the hepatic veins and restrictive filling patterns in the right atrium are indicative.

  • Cardiac Magnetic Resonance Imaging (MRI): Particularly useful for distinguishing inflammatory constriction that may respond to anti-inflammatory therapy:
  • - Late Gadolinium Enhancement (LGE): Can show areas of pericardial inflammation or fibrosis. - T1 Mapping: Provides quantitative assessment of myocardial and pericardial tissue characteristics, aiding in differentiating between constrictive pericarditis and restrictive cardiomyopathy.

    Differential diagnoses to consider include restrictive cardiomyopathy, chronic effusive pericarditis, and restrictive pericardial syndromes secondary to other causes (e.g., radiation, uremia). Careful correlation of clinical findings with imaging results is crucial to rule out these conditions and confirm the diagnosis of constrictive pericarditis.

    Management

    The management of viral-induced constrictive pericarditis primarily focuses on definitive surgical intervention, given the limited efficacy of medical therapy in chronic cases. Key aspects of management include:

    Medical Management

  • Supportive Care: Includes diuretics for managing fluid overload, particularly in the presence of peripheral edema and ascites.
  • Optimization of Heart Failure Medications: Use of ACE inhibitors, beta-blockers, and aldosterone antagonists as tolerated, focusing on maintaining cardiac function and reducing symptoms.
  • Anti-inflammatory Therapy: In cases where inflammation is suspected and surgical intervention is not immediately feasible, corticosteroids might be considered, though evidence is limited and outcomes vary [PMID:25725605].
  • Surgical Intervention

  • Complete Pericardiectomy: Remains the definitive treatment for chronic constrictive pericarditis. This procedure involves the complete removal of the pericardium to relieve constriction and restore normal cardiac hemodynamics.
  • - Surgical Indications: Indicated for patients with persistent symptoms despite medical management, significant hemodynamic compromise, or diagnostic certainty from imaging studies. - Post-Operative Monitoring: Close monitoring post-surgery includes serial echocardiograms to assess for normalization of diastolic function and clinical follow-up to evaluate symptom resolution. - Outcome: Successful pericardiectomy often results in significant symptomatic improvement and normalization of echocardiographic findings, as seen in a case where post-operative echocardiography demonstrated reversal of constrictive features and resolution of symptoms [PMID:23757998].

    Monitoring and Follow-Up

  • Regular Echocardiography: Scheduled at intervals (e.g., 3-6 months post-surgery) to monitor cardiac function and ensure no recurrence of constrictive features.
  • Clinical Assessment: Regular follow-up visits to assess symptom status, physical examination findings, and quality of life improvements.
  • Long-Term Prognosis: While surgical pericardiectomy can lead to significant clinical improvement, long-term outcomes vary. Patients may require ongoing management for residual heart failure symptoms or complications related to the underlying viral etiology.
  • Key Recommendations

  • Consider Constrictive Pericarditis in patients presenting with unexplained right heart failure symptoms, especially with preserved LVEF.
  • Utilize Comprehensive Echocardiography as the primary diagnostic tool, supplemented by cardiac MRI for detailed tissue characterization.
  • Initiate Supportive Medical Therapy for symptom management, including diuretics and heart failure medications.
  • Consider Anti-inflammatory Therapy cautiously in selected cases where surgery is delayed.
  • Advise Surgical Pericardiectomy for definitive treatment in chronic cases with persistent symptoms or hemodynamic instability.
  • Implement Rigorous Post-Operative Monitoring including serial echocardiograms and clinical assessments to ensure recovery and detect recurrence early.
  • Provide Long-Term Follow-Up to manage potential residual symptoms and monitor overall cardiac function and quality of life.
  • References

    1 Welch TD, Oh JK. Constrictive pericarditis: old disease, new approaches. Current cardiology reports 2015. link 2 Laghari AH, Tai JM. Heavily thickened pericardium with constrictive pericarditis. JPMA. The Journal of the Pakistan Medical Association 2013. link

    2 papers cited of 3 indexed.

    Original source

    1. [1]
      Constrictive pericarditis: old disease, new approaches.Welch TD, Oh JK Current cardiology reports (2015)
    2. [2]
      Heavily thickened pericardium with constrictive pericarditis.Laghari AH, Tai JM JPMA. The Journal of the Pakistan Medical Association (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG